Results 231 to 240 of about 51,915,563 (304)

Repurposing FDA‐Approved Drugs to Inhibit Fungal PPTases for Broad‐Spectrum Synergy

open access: yesAdvanced Science, EarlyView.
Fungal secondary metabolites serve as crucial virulence effectors; however, the potential of their biosynthetic pathways as antifungal targets remains inadequately comprehended. Repurposed FDA‐approved drugs inhibit fungal PPTase (essential for secondary metabolism) in vivo.
Zili Song   +7 more
wiley   +1 more source

Social marketing intervention for social media-related adolescent risk behaviours in North India: A multi-city cluster RCT protocol. [PDF]

open access: yesPLoS One
Kiran T   +9 more
europepmc   +1 more source

Editorial: Insights and innovations in consumer neuroscience. [PDF]

open access: yesFront Hum Neurosci
Valesi R, Zito M, Casiraghi C, Russo V.
europepmc   +1 more source

Home - About - Disclaimer - Privacy